Bioactive peptides: signaling the future


  • Cited companies
    Allergan, Inc. (Irvine, CA)
    Atrium Biotechnologies (Quebec City, Canada)
    Grant Industries (Elmwood, NJ)
    Lipotec (Barcelona, Spain)
    Pentapharm (Basel, Switzerland)
    Sederma (Le Perray en Yvelines, France)

L Bush, 111 Maiden Lane, Suite 600, San Francisco, CA 94108. E-mail:


Natural processes within the body are modulated almost exclusively by the interaction of specific amino acid sequences, either as peptides or as subsections of proteins. With respect to skin, proteins and peptides are involved in the modulation of cell proliferation, cell migration, inflammation, angiogenesis, melanogenesis, and protein synthesis and regulation. The creation of therapeutic or bioactive peptide analogs of specific interactive sequences has opened the door to a diverse new field of pharmaceutical and active cosmetic ingredients for the skincare industry. Here, we describe the origin of such sequences, their role in nature, their application to dermatology, as well as the advantages and challenges posed by this new technology.